FMC, DE0005785802

FMC stock ends the day modestly lower at the close on the NYSE

Published on 09/21/2026 at 23:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, FMC stock, representing the U.S.-listed shares of Fresenius Medical Care, finished the regular session on the NYSE slightly below its prior close, lagging a broadly positive U.S. equity market as the company continued to update investors on its share buyback program.

Moderner Dialyseraum mit Hämodialysegeräten und Patientenliegen bei Tageslicht
Ein fotorealistisches Bild eines modernen Dialyseraums mit mehreren Hämodialysegeräten und Patientenliegen in Reihe, ruhigem Tageslicht durch große Fenster – typisch für die Behandlungszentren von Fresenius Medical Care AG (ISIN DE0005785802), Illustration mit AI erstellt.

FMC stock, representing the U.S.-listed shares of Fresenius Medical Care, closed on the NYSE at USD 38.10 on September 21, 2026, down 0.52 percent from the prior close. Compared with the S&P 500, which added about 1.33 percent on the day per broad market data, the stock underperformed the wider U.S. market.

September 21, 2026 in numbers

Fresenius Medical Care AG (ISIN DE0005785802) opened the U.S. regular session on the NYSE near USD 38.40 and traded between an intraday low around USD 37.90 and a high close to USD 38.70, finishing the day in the lower half of that range. The close of USD 38.10 remained comfortably within the stock’s 52-week span on the U.S. market, which currently runs between roughly USD 30 in the trough and USD 45 at the peak for this listing. On Xetra, the home-market shares had most recently closed at EUR 38.53 on September 19, 2026, a decline of 2.75 percent, with the official auction stamped shortly after the end of continuous trading at 11:30 a.m. ET, underscoring weaker sentiment in the German session earlier in the week as reported by Ad-hoc-news. Today’s U.S. trading volume stayed within a normal band relative to the average daily turnover reported by major U.S. quote services, indicating a calm session without unusual activity.

After the bell and the next session

After the close on September 21, 2026, Fresenius Medical Care continued to update the market on its ongoing share buyback program. From September 14 to 18, 2026 the company repurchased 209,200 shares under its first tranche, bringing total shares acquired in that tranche to 8,984,175, according to a capital-market notice summarized by TradingView. An additional release classified as “other capital market information” for Fresenius Medical Care appeared later in the European afternoon, as shown in the event overview of EQS News, and investors will watch follow-up disclosures after the bell today. In after-hours trading, FMC stock was little changed from its regular-session close, with sporadic prints on the NYSE’s electronic venue around the USD 38 level before 5:30 p.m. ET, suggesting a neutral initial reaction as the extended session continued.

Disclaimer...

en | DE0005785802 | FMC | boerse | 70147453 | bgmi